| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry; human; 1:150; loading ...; fig 5a
| Malinowski D, Grzeg xf3 x142 kowski P, Piotrowska K, S x142 ojewski M, Dro x17a dzik M. Membrane Transporters and Carriers in Human Seminal Vesicles. J Clin Med. 2022;11: pubmed publisher |
- western blot; human; fig 5b
| Neradugomma N, Liao M, Mao Q. Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts. Mol Pharmacol. 2017;91:237-249 pubmed publisher |
- western blot; human; 1:500; fig 4
| Gao C, Zhang J, Wang Q, Ren C. Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemia. Oncol Lett. 2016;12:1051-1057 pubmed |
- western blot; human; fig 1
| Rigalli J, Ciriaci N, Arias A, Ceballos M, Villanueva S, Luquita M, et al. Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity. PLoS ONE. 2015;10:e0119502 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:500
| Dalley A, Pitty L, Major A, Abdulmajeed A, Farah C. Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma. Cancer Med. 2014;3:273-83 pubmed publisher |
| Lee S, Lee H, Park G, Oh S, Oh D. Dual actions on gout flare and acute kidney injury along with enhanced renal transporter activities by Yokuininto, a Kampo medicine. BMC Complement Altern Med. 2019;19:57 pubmed publisher |
| Zhang Z, Guo X, To K, Chen Z, Fang X, Luo M, et al. Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo. Acta Pharm Sin B. 2018;8:563-574 pubmed publisher |
| Kim B, Fatayer H, Hanby A, Horgan K, Perry S, Valleley E, et al. Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer. PLoS ONE. 2013;8:e62766 pubmed publisher |
| Tiwari A, Zhang R, Gallo J. Overlapping functions of ABC transporters in topotecan disposition as determined in gene knockout mouse models. Mol Cancer Ther. 2013;12:1343-55 pubmed publisher |
| Han H, Bourboulia D, Jensen Taubman S, Isaac B, Wei B, Stetler Stevenson W. An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells. Oncogene. 2014;33:1198-206 pubmed publisher |
| Carina V, Zito G, Pizzolanti G, Richiusa P, Criscimanna A, Rodolico V, et al. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2. Thyroid. 2013;23:829-37 pubmed publisher |
| Flores Martín J, Rena V, Marquez S, Panzetta Dutari G, Genti Raimondi S. StarD7 knockdown modulates ABCG2 expression, cell migration, proliferation, and differentiation of human choriocarcinoma JEG-3 cells. PLoS ONE. 2012;7:e44152 pubmed publisher |
| Dubrovska A, Hartung A, Bouchez L, Walker J, Reddy V, Cho C, et al. CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling. Br J Cancer. 2012;107:43-52 pubmed publisher |
| Ridano M, Racca A, Flores Martín J, Camolotto S, de Potas G, Genti Raimondi S, et al. Chlorpyrifos modifies the expression of genes involved in human placental function. Reprod Toxicol. 2012;33:331-8 pubmed publisher |
| Hang D, Dong H, Ning T, Dong B, Hou D, Xu W. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Dis Esophagus. 2012;25:638-44 pubmed publisher |
| Konieczna A, Erdosova B, Lichnovska R, Jandl M, Cížková K, Ehrmann J. Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos. J Mol Histol. 2011;42:567-74 pubmed publisher |
| Liu W, Feng J, Shen X, Wang H, Liu Y, Zhou Z. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer. 2012;118:1693-700 pubmed publisher |
| Saghizadeh M, Soleymani S, Harounian A, Bhakta B, Troyanovsky S, Brunken W, et al. Alterations of epithelial stem cell marker patterns in human diabetic corneas and effects of c-met gene therapy. Mol Vis. 2011;17:2177-90 pubmed |
| Chen Y, Huang W, Wei Y, Hsu S, Yuan P, Lin H, et al. Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells. PLoS ONE. 2011;6:e21428 pubmed publisher |
| Garrido W, Munoz M, San Martin R, Quezada C. FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1. Biochem Biophys Res Commun. 2011;411:62-8 pubmed publisher |
| Peigñan L, Garrido W, Segura R, Melo R, Rojas D, Cárcamo J, et al. Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro. Neurochem Res. 2011;36:1397-406 pubmed publisher |
| Ek C, Wong A, Liddelow S, Johansson P, Dziegielewska K, Saunders N. Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol Lett. 2010;197:51-9 pubmed publisher |
| Jendželovský R, Mikes J, Kovaľ J, Soucek K, Prochazkova J, Kello M, et al. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells. Photochem Photobiol Sci. 2009;8:1716-23 pubmed publisher |
| Guo J, Anderson M, Tapang P, Palma J, Rodriguez L, Niquette A, et al. Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152. Pharmacogenomics J. 2009;9:90-102 pubmed publisher |
